ClinicalTrials.gg
Status unknownNCT03363490Updated Apr 6, 2018

The Study of Neuromuscular Exercise Therapy and Patients Self-management Program in Knee Osteoarthritis

An interventional study of Self-management program and Neuromuscular exercise therapy in Exercise Therapy, sponsored by Peking University People's Hospital. Status unknown at 1 site in China. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2018-04-06.

Sponsored by Peking University People's Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
50 Years and older
Sex
All
01

Study summary

Osteoarthritis is the most common chronic disabling disease,the importance of patient's self-management in chronic disease has been paid more and more attention internationally. Currently, the self-management of OA patients in China is lack of instructions from professional clinicians, and leads to inappropriate excise, irregular drug medication. OAKP (Osteoarthritis of the Knee Self-Management Program) is a program initiated from University of Southern Denmark, follows clinical guidelines of OA, formatted for easy use by patients and clinicians, including customized neuromuscular exercise therapy, educational sessions of what is OA and how to control body weight to protect the knee.

The main purpose of this study is to verify the effectiveness of neuromuscular exercise therapy and OAKP, see whether it can help patients to relief the symptom and improve life quality.

Read the detailed description

The study plans to enroll patients above 50 years old who suffered from knee OA, but patients meets any of the exclusion criteria will not be enrolled. 400 patients of knee OA will be randomly divided into A, B, C, D four parallel groups with fully informed, each group will enroll 100 patients, A for control group, B for neuromuscular exercise, C for self-management program, D for neuromuscular exercise and self-management program, respectively. Each collaborate hospital would enroll patients as a multicenter clinical trial. Patient will receive a baseline and 3m, 6m, 12m follow-up evaluation of their knee physical function. Primary outcome measure is KOOS (Knee Injury and Osteoarthritis Outcome Score), secondary evaluation include VAS, EQ-5D, Arthritis self-efficacy score, 6-minutes Walk test, TUG test, 20 meters quick walk test,Stand up test in 30 seconds, Balance test, Kellgren\& Lawrence(KL), Pain medication. Outcome will compare the mean difference between baseline survey and 12 months of follow-up in each group, using t-test or chi-square test,respectively.

02

Conditions studied

  • Exercise Therapy

Keywords

  • Self-Management
  • Neuromuscular Exercise Therapy
  • Knee osteoarthritis
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's planned enrollment of 400 is above the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Peking University People's Hospital is the lead sponsor of 603 studies on the registry; 241 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-

1.Clinical diagnosis of knee osteoarthritis, Diagnostic criteria is based on the Chinese medical association's 2007 diagnosis and treatment guidelines for osteoarthritis:

  1. Repeated knee joint pain within 1 month;
  2. X-ray(weight-bearing or not)shows narrowed joint space,sclerosis and (or) cystic degeneration of subchondral bone, osteophytes of the joints;
  3. The joint fluid (at least twice) is clear and viscous, WBC\<2000个/ml;
  4. Age of patients ≥40 yrs;
  5. Morning stiffness≤3 min;
  6. Bone friction in the activity; Note:Combine clinical feature, laboratory and X-ray examination,when the patients meet(1)+(2) or (1)+(3)+(5)+(6) or (1)+(4)+(5)+(6),they can be diagnosis as knee osteoarthritis.

2.VAS≥4分; 3.No surgical treatment is planned within 6 months;

Exclusion criteria

Exclusion Criteria:

  1. Other types of arthritis, such us RA(rheumatoid arthritis)
  2. Severe deformity of knee joint;
  3. Over obesity patients(BMI>35);
  4. Other comorbidities that would severely affect somatic function, such as: cerebral infarction, lumbar disease that meets surgical indications, lower extremity angiopathy;
  5. Decompensated cardiac dysfunction;
  6. Severe cardiovascular and cerebrovascular diseases, or the patient is too weak for any kinds of exercise;
  7. Lack of compliance;
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • Other
    Control

    The patients in this group will only receive health education intervention.

    Behavioral: Health education

  • Other
    Neuromuscular exercise therapy

    The patients in this group will receive exercise therapy intervention.Besides, health education will be performed for every group.

    Behavioral: Neuromuscular exercise therapy · Behavioral: Health education

  • Other
    Self-management program

    The patients in this group will receive self-management intervention.Besides, health education will be performed for every group.

    Behavioral: Self-management program · Behavioral: Health education

  • Other
    Exercise therapy+self-management

    The patients in this group will receive exercise therapy and self-management intervention.Besides, health education will be performed for every group.

    Behavioral: Self-management program · Behavioral: Neuromuscular exercise therapy · Behavioral: Health education

Interventions

  • BehavioralSelf-management program

    Self-management diary will record the frequency of pain, fatigue and injury of knee joint due to knee OA, if patients maintain proper activities, it will be also recorded by an smart phone APP. Patients diet and intake calorie will also be recorded in the diary,which help clinicians to adjust their diet, control their body weight.

  • BehavioralNeuromuscular exercise therapy

    The exercise therapy is basically combined with neuromuscular training and anti resistance training. The aim is to improve the stability of the joints, enhance sensory motor control of lower extremities, reconstruct neutral position line. The exercise mode, frequency, intensity and duration will be adjusted individually through monitoring patient's pain.

  • BehavioralHealth education

    All four groups of patient will receive two times of health education in the first week.

06

What researchers measure

Primary outcomes

  1. The Western Ontario and McMaster Universities Osteoarthritis Index,WOMAC

    WOMAC grade is a reliable knee osteoarthritis patients' self-reported therapeutic effect evaluation system, including three dimensions: pain, stiffness, daily activities and quality of life, and each dimension includes several questions scale from 0(worst) to 4(best) , total score of each dimension range from zero (worst) to 100 (best). Score of each question add together will be the total score. Baseline, 3 months, 6 months, 12 months, through visit or telephone follow-up will be recorded. Compare the mean difference of WOMAC grade between baseline survey and 12 months of follow-up in each group.

    Time frame: Baseline, 3 months, 6 months, 12months

Secondary outcomes

  1. Visual Analog Score(VAS)

    Visual Analogue Scale of pain is a scale to extimate pain, and its score ranges from 0(worst) to 10(best). The higher the score is, the more severe pain the patient is feeling.

    Time frame: Baseline, 3 months, 6 months, 12months

  2. EuroQol Five Dimensions Questionnaire(EQ-5D)

    EQ-5D is a scale to extimate health condition and quality of life, and its score ranges from -0.6 to 1.0. The higher the score is, the healthier the patient is.

    Time frame: Baseline, 3 months, 6 months, 12months

  3. Kellgren& Lawrence(KL)

    The higher the KL score is ,the more severe the patient is. Baseline,through visit or telephone follow-up.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • PekingUPH
    Beijing, Beijing Municipality, China
    • Yifan Chen, Resident · Contact · chenyifan_cn@163.com · 15810031180
    • Rujun Li, Attending · Contact · 15810963512
    Recruiting
08

References and documents

Publications

  • Ageberg E, Roos EM. Neuromuscular exercise as treatment of degenerative knee disease. Exerc Sport Sci Rev. 2015 Jan;43(1):14-22. doi: 10.1249/JES.0000000000000030. PubMed 25390299 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2018 (actual). Primary completion is estimated for Dec 2019, 20 months after the start.

Of 1,143 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 20 months is above that.

Counting every sponsor, half of 1,285 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2017
First posted
Dec 6, 2017
StartActual
Apr 1, 2018
Primary completionEst.
Dec 31, 2019
CompletionEst.
Dec 31, 2019
Last update
Apr 6, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03363490
Collaborators
Beijing Jishuitan Hospital, General Hospital of Beijing PLA Military Region, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Fuwai Hospital
Responsible party
Lin Jianhao (Clinical Research Center of Osteoarthritis, Peking University People's Hospital) — Principal investigator
First posted
Dec 6, 2017
Start date
Apr 1, 2018
Primary completion
Dec 31, 2019 (estimated)
Completion
Dec 31, 2019 (estimated)
Last update
Apr 6, 2018

Study contacts

Yifan Chen
Contact
chenyifan_cn@163.com
15810031180
Rujun Li, Attending
Contact
15810963512
Jianhao Lin, MD
principal investigator · arthritic clinic and research center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion